Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPandey, Ashok-
dc.contributor.authorBelbase, Pradeep-
dc.contributor.authorParajuli, Ayuska-
dc.identifier.citationPandeyA., BelbaseP., & ParajuliA. (2021). COVID-19 Vaccine Development to Vaccination. Journal of Nepal Health Research Council, 18(4), 807-809.
dc.identifier.issnPrint ISSN: 1727-5482; Online ISSN: 1999-6217-
dc.description.abstractAbstract In the race for a safe and effective vaccine against Coronavirus disease-19 manufacturer plays a critical role throughout the development, clinical trial, manufacturing, supply, and vaccination phases. For the efficacy of Coronavirus disease-19 vaccine, proper transport, storage, vaccine carrier, adjuvant, dosage form and route of vaccine administration plays a crucial role for immune response. In the context of no more people were willing to pay for a Coronavirus disease-19 vaccine the logistics of manufacturing, storing and distributing the vaccine, and mass vaccination are essential. It is urgent to improve health promotion and reduce the barriers to Coronavirus disease-19 vaccination. Keywords: COVID-19; vaccine development; vaccinationen_US
dc.publisherNepal Health Research Councilen_US
dc.relation.ispartofseriesOct-Dec, 2020;3351-
dc.subjectVaccine developmenten_US
dc.titleCOVID-19 Vaccine Development to Vaccinationen_US
dc.typeJournal Articleen_US
Appears in Collections:Vol. 18 No. 4 (2020): Vol. 18 No. 4 Issue 49 Oct-Dec 2020

Files in This Item:
File Description SizeFormat 
3351-Manuscript-20028-1-10-20210122.pdfFulltext Download184.48 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.